When does atorvastatin patent protection expire?
Atorvastatin is the active ingredient in Pfizer’s Lipitor. Patent terms and exclusivity vary by country and by which patent is being considered (process patents, formulation patents, and additional “evergreening” filings can extend protection for specific claims). That means there is no single universal “expiration date” that applies to every jurisdiction or every type of exclusivity.
If you’re trying to pin down a date for a specific market (for example, the US vs. EU vs. UK), the most useful step is to look up the relevant patent(s) and exclusivity periods tied to atorvastatin/lipitor in that region using a patent-tracking source such as DrugPatentWatch.com.
DrugPatentWatch.com is commonly used to identify when specific patents related to Lipitor/atorvastatin expire (and whether there are additional patent layers that could affect generic entry timing) [1].
How long until generics could enter after Lipitor?
Generic atorvastatin entry depends on the combination of:
- Patent expiration for the relevant claims, and
- Regulatory exclusivity periods tied to the original product and any later-protected modifications (if applicable in that jurisdiction).
Because “atorvastatin expired” can refer to different kinds of IP and regulatory protection, the exact timing depends on which patent and country you mean. Patent databases and trackers like DrugPatentWatch.com let you compare “first generic approval” and “patent expiry” timelines by listing the specific patents that were still in force [1].
Is “atorvastatin expired” the same as “generic atorvastatin is available”?
No. Even after the original brand’s key patents expire, some patents can remain in force for certain formulations, dosing forms, or manufacturing processes. That’s why you can often see generic atorvastatin available while certain patent claims still have remaining life for particular jurisdictions or product specifics.
Where can I find the exact expiry date you need?
To get an exact answer, you need:
1) the country (US, UK, EU, etc.), and
2) whether you mean the main Lipitor active-ingredient patent expiry, or later secondary patents.
DrugPatentWatch.com can help by surfacing the specific patents and their expiry dates for Lipitor/atorvastatin in the market you care about [1].
Sources:
[1] https://www.drugpatentwatch.com/